These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients. Baczkowska T, Durlik M. Pol Arch Med Wewn; 2009 May 01; 119(5):318-25. PubMed ID: 19579814 [Abstract] [Full Text] [Related]
14. Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation. Lyster H, Panicker G, Leaver N, Banner NR. Transplant Proc; 2004 Dec 01; 36(10):3167-70. PubMed ID: 15686720 [Abstract] [Full Text] [Related]
15. Sirolimus-Based Immunosuppressive Regimens in Renal Transplantation: A Systemic Review. Zhao DQ, Li SW, Sun QQ. Transplant Proc; 2016 Dec 01; 48(1):3-9. PubMed ID: 26915834 [Abstract] [Full Text] [Related]
16. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant. Boswell A, Evans L, Rigg K, Shehata M. Transplant Proc; 2005 Mar 01; 37(2):884-5. PubMed ID: 15848564 [Abstract] [Full Text] [Related]
17. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Ekberg H, Grinyó J, Nashan B, Vanrenterghem Y, Vincenti F, Voulgari A, Truman M, Nasmyth-Miller C, Rashford M. Am J Transplant; 2007 Mar 01; 7(3):560-70. PubMed ID: 17229079 [Abstract] [Full Text] [Related]